| Annual Financials | 2023 | 2024 | 2025 | TTM |
Revenue  | 16 | 15 | 38 | 0 |
| Expenses | 15 | 10 | 23 | 0 |
| EBITDA | 2 | 6 | 15 | 0 |
| Operating Profit % | 10 % | 37 % | 40 % | 0 % |
| Depreciation | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 0 |
| Profit Before Tax | 1 | 4 | 13 | 0 |
| Tax | 0 | 1 | 3 | 0 |
| Net Profit | 0 | 3 | 10 | 0 |
| EPS in ₹ | 0.36 | 2.72 | 10.67 | 0.00 |
Bio Medica Laboratories
Bio Medica Laboratories
139.50
+9.50
(7.31%)
Market Cap
175.42 Cr
PE Ratio
-
Volume
1,97,000.00
Day High - Low
141.00 - 130.00
52W High-Low
148.00 - 101.50
Key Fundamentals
Market Cap
175.42 Cr
EPS
10.67
PE Ratio
-
PB Ratio
-
Book Value
49.24
EBITDA
15.30
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
66.48
Debt to Equity
1.30
Actual
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,921.40 | #1 4,61,008.22 | 40.34 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 64.42 | |
6,938.50 | 1,84,195.37 | 70.67 | 10,560.00 | 8.73 | 2,520 | 13.44 | 62.61 | |
4,951.10 | 1,67,567.72 | 77.61 | 13,886.20 | 20.34 | 2,138 | -26.91 | 78.08 | |
1,426.70 | 1,15,255.29 | 30.10 | 29,044.60 | 2.24 | 3,870 | -55.32 | 51.98 | |
2,492.60 | 1,13,969.78 | #1 21.31 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 67.70 | |
1,131.30 | 1,13,835.25 | 22.40 | 26,719.70 | 13.65 | 5,242 | 7.82 | 58.18 | |
2,507.50 | 1,03,558.74 | 53.80 | 14,277.60 | 12.03 | 1,750 | 31.75 | 55.47 | |
1,234.50 | 1,03,039.90 | 25.01 | 35,058.60 | 3.90 | 4,158 | -86.05 | 34.07 | |
1,549.30 | 89,143.30 | 25.94 | 33,384.70 | 3.21 | 3,376 | 1.99 | 54.05 | |
1,558.60 | 84,142.05 | 93.34 | 6,867.80 | #1 22.01 | 890 | 21.18 | 66.92 |
Growth Rate
Revenue Growth
150.33 %
Net Income Growth
292.00 %
Cash Flow Change
-326.54 %
ROE
31.38 %
ROCE
82.15 %
EBITDA Margin (Avg.)
7.26 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 | 2025 |
| Total Assets | 18 | 20 | 39 |
| Fixed Assets | 8 | 9 | 8 |
| Current Assets | 9 | 11 | 31 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 9 | 11 | 31 |
| Total Equity & Liabilities | 18 | 20 | 39 |
| Current Liabilities | 10 | 7 | 17 |
| Non Current Liabilities | 5 | 8 | 7 |
| Total Equity | 2 | 5 | 15 |
| Reserve & Surplus | 2 | 5 | 6 |
| Share Capital | 0 | 0 | 9 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | -2 | 0 | 0 |
| Investing Activities | -2 | -2 | 0 |
| Operating Activities | 2 | 2 | -4 |
| Financing Activities | -2 | -0 | 3 |
Share Holding
| % Holding | Aug 2025 | May 2026 |
| Promoter | 100.00 % | 67.70 % |
| FIIs | 0.00 % | 0.29 % |
| DIIs | 0.00 % | 2.31 % |
| Government | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 21.38 % |
| Others | 0.00 % | 8.33 % |
| No of Share Holders | 0 | 1,195 |
Technical Indicators
RSI(14)
Neutral 50.27
ATR(14)
Less Volatile 7.62
STOCH(9,6)
Neutral 32.68
STOCH RSI(14)
Neutral 22.47
MACD(12,26)
Bearish 0.00
ADX(14)
Strong Trend 39.05
UO(9)
Bearish 34.74
ROC(12)
Downtrend And Accelerating -4.06
WillR(14)
Neutral -62.28
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
